News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GenSpera Enters Agreement with University of Copenhagen for Production Of Thapsigargin


6/29/2011 9:01:54 AM

SAN ANTONIO--(BUSINESS WIRE)--GenSpera, Inc. (OTCBB:GNSZ) has entered into a cooperation agreement with the University of Copenhagen, in Copenhagen, Denmark, to collaborate on the “SPOTLight” (Sustainable Production of Thapsigargin using Light) project. The goal of the project is to develop a metabolically engineered moss strain as a sustainable production platform for high-value plant products. Production of thapsigargin has been chosen as the first pilot project.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES